The legislation would require the U.S. Secretary of Health and Human Services to negotiate directly with drug manufacturers over the price of some high-cost drugs in the Medicare program.

Proposals include capping out-of-pocket medication costs for Medicare recipients at $2,000 per year and insulin at $35 per month.

As the election nears, here is a brief breakdown of what Trump has done — and has not done — on some key health issues.